Patents Assigned to Max-Planck Gesellschaft zur Forderung des Wissenschaften E.V.
  • compounds and anti-infection applications thereof
    Patent number: 7422754
    Abstract: The invention provides novel Neisseria meningitides (Nm) polypeptides and polynucleotides which cover the Nm genetic diversity, and which correspond to polypeptide of Nm outer membrane and/or periplasma, and to methods for producing such Nm compounds. Also provided are anti-Nm infection, and particularly diagnostic. prophylactic and therapeutic uses thereof.
    Type: Grant
    Filed: May 14, 2004
    Date of Patent: September 9, 2008
    Assignees: Institut National de la Sante et de la Recherche Medicale (Inserm), Max-Planck Gesellschaft zur Forderung des Wissenschaften E.V.
    Inventors: Xavier Nassif, Colin Tinsley, Silke Klee, Mark Achtman, Petra Merker
  • DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof
    Publication number: 20070105225
    Abstract: The DNA of the invention are characterised in that they concern the whole or part of genes, with their reading frame, to be found in Neisseria meningitidis but not in Neisseria gonorrhoeae, or in Neisseria lactamica except the genes involved in the biosynthesis of the polysaccharide capsule, frp A, frp C, opc, por A, rotamase the sequence IC1106, IgA protease, pilline, pilC, transferrin binding proteins and opacity proteins. The invention also concerns the polypeptides corresponding to these DNA and the antibodies directed against these polypeptides. It is applicable in the prevention and the detection of meningococcus induced infections and meningitis.
    Type: Application
    Filed: December 14, 2006
    Publication date: May 10, 2007
    Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (I.N.S.E.R.M.), MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DES WISSENSCHAFTEN E.V., SMITHKLINE BEECHAM
    Inventors: Xavier Nassif, Colin Tinsley
  • DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof
    Publication number: 20070082361
    Abstract: The DNA of the invention are characterised in that they concern the whole or part of genes, with their reading frame, to be found in Neisseria meningitidis, but not in Neisseria gonorrhoeae, or in Neisseria lactamica except the genes involved in the biosynthesis of the polysaccharide capsule, frp A, frp C, opc , por A, rotarmase the sequence IC1106, IgA protease, pilline, pilC, transferrin binding proteins and opacity proteins. The invention also concerns the polypeptides corresponding to these DNA and the antibodies directed against these polypeptides. It is applicable in the prevention and the detection of meningococcus induced infections and meningitis.
    Type: Application
    Filed: December 14, 2006
    Publication date: April 12, 2007
    Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (I.N.S.E.R.M), MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DES WISSENSCHAFTEN E.V., SMITHKLINE BEECHAM
    Inventors: Xavier Nassif, Colin Tinsley
  • DNA and proteins or peptides specific of the Neisseria meningitidis species bacteria, method for obtaining them and their biological applications
    Publication number: 20060063167
    Abstract: The DNA of the invention are characterised in that they concern the whole or part of genes, with their reading frame, to be found in Neisseria meningitidis, but not in Neisseria gonorrhoeae, or in Neisseria lactamica except the genes involved in the biosynthesis of the polysaccharide capsule, frp A, frp C, opc, por A, rotamase the sequence IC1106, IgA protease, pilline, pilC, transferrin binding proteins and opacity proteins. The invention also concerns the polypeptides corresponding to these DNA and the antibodies directed against these polypeptides. It is applicable in the prevention and the detection of meningococcus induced infections and meningitis.
    Type: Application
    Filed: January 31, 2005
    Publication date: March 23, 2006
    Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (I.N.S.E.R.M), MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DES WISSENSCHAFTEN E.V., SmithKline Beecham
    Inventors: Xavier Nassif, Colin Tinsley, Mark Achtman, Jean-Louis Ruelle, Carla Vinals, Petra Merker
  • Novel Neisseria meningitidis compounds and anti-infection applications thereof
    Publication number: 20050089527
    Abstract: The invention provides novel Neisseria meningitides (Nm) polypeptides and polynucleotides which cover the Nm genetic diversity, and which correspond to polypeptide of Nm outer membrane and/or periplasma, and to methods for producing such Nm compounds. Also provided are anti-Nm infection, and particularly diagnostic. prophylactic and therapeutic uses thereof.
    Type: Application
    Filed: May 14, 2004
    Publication date: April 28, 2005
    Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), MAX-PLANCK GESELLSCHAFT ZUR FORDERUNG DES WISSENSCHAFTEN E.V.
    Inventors: Xavier Nassif, Colin Tinsley, Silke Klee, Mark Achtman, Petra Merker